0001127602-21-009214.txt : 20210303 0001127602-21-009214.hdr.sgml : 20210303 20210303164740 ACCESSION NUMBER: 0001127602-21-009214 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210301 FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAPA JOSEPH C CENTRAL INDEX KEY: 0001242215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 21709877 MAIL ADDRESS: STREET 1: C/O WATSON PHARMACEUTICALS INC STREET 2: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-03-01 0000885590 Bausch Health Companies Inc. BHC 0001242215 PAPA JOSEPH C 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 1 1 CHAIRMAN & CEO Common Shares, No Par Value 2021-03-01 4 F 0 28192 31.42 D 771673 D This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. /s/ Kirsten O'Donnell, attorney-in-fact for Joseph C. Papa 2021-03-03